Stephen_Marr

Stephen Marr

Head of Real Estate, Facilities and Capital Programs, Spark Therapeutics, Inc.

A global biopharmaceutical executive with extensive experience leading large organizations with up to 4,000 team members, Steve joined Spark in 2020 as the Head of Real Estate, Facilities and Capital Programs where he is responsible for leading the evolution of Spark’s expanding corporate facilities portfolio and long-term facilities strategy.

Prior to joining Spark, Steve spent 26 years in the United States Navy as a nuclear submarine officer where he held several key leadership positions including Commanding Officer of the USS Salt Lake City, as well as Commodore of Submarine Squadron One in Pearl Harbor, Hawaii. After retiring from the Navy as a Captain in 2009, Steve spent four years in the civilian nuclear industry working for Areva and then Westinghouse as a Project Director for large multi-billion-dollar new nuclear facilities. In 2014 Steve transitioned to the pharmaceutical industry, joining Shire Pharmaceuticals as a Project Director and site lead where he and his team successfully delivered a new $2B manufacturing facility. Steve also spent three years as the Head of Capital Programs for Shire where he was accountable for developing and implementing capital management programs and services with direct oversight of their $1B annual capital budget.

Originally from Longmeadow, Massachusetts, Steve earned a B.S. in Ocean Engineering from the United States Naval Academy.


Appearances

  • Thumbnail for Designing a Gene Therapy Factory That Flexes for the Future
    Date
    January 29, 2024
    By definition, Gene therapy technology and manufacturing is constantly evolving, which presents unique challenges in terms of facility design, coupled with ongoing shifts in platform, process and capacity…

    Speakers

    Speaker Image for Stephen Marr
    Head of Real Estate, Facilities and Capital Programs, Spark Therapeutics, Inc.
    Speaker Image for Curt Biehn
    Director of Life Sciences Solutions, Jacobs Engineering Group Inc
    Speaker Image for Christine Sheaffer
    Head of Manufacturing & Supply, Spark
  • Thumbnail for Transformation into ATMP
    Date
    October 16, 2023
    It's remarkable how rapidly the field of ATMP development is advancing, with more and more organizations entering this space. In this session, we'll take a closer look at how a conventional biologics manufacturing facility was transformed into a modern, multi-modal facility for ATMP products…

    Session Leader

    Speaker Image for Shanshan Liu
    Technical Director, No Deviation Pte Ltd

    Speakers

    Speaker Image for Stephen Marr
    Head of Real Estate, Facilities and Capital Programs, Spark Therapeutics, Inc.
    Speaker Image for Drew Johnston
    Vice President Site Engineering, Bayer
    Speaker Image for James Green
    Director Platform Engineering, Bayer
    Speaker Image for Gregory Gara
    Vice President of Pharmaceutical Engineering, Sarepta Therapeutics
    Speaker Image for Adam Barlow
    Rincipal and Founder, Baseline Controls, Inc
    Speaker Image for Adam Pfeiffer
    VP of Strategy, Project Farma
    Speaker Image for Andrew Slusser
    Senior Director of Architecture/ Process Architecture SME, PM Group
    Speaker Image for Michael Greening
    Head of Project Delivery US (Exec Director), Genentech Inc
    Speaker Image for Aaron Allen
    Director, Global Quality, Moderna Therapeutics